Native T1 is independently associated with aerobic exercise capacity in long-term follow-up after mild initial...

Exercise intolerance is a common and incapacitating long-term consequence of coronavirus disease (COVID-19), even after mild acute illness. Cardiovascular magnetic resonance (CMR) studies have demonstrated persistent perimyocardial inflammatory abnormalities; however, their relationship with long-term aerobic capacity remains unclear.

In this prospective observational study, individuals without prior structural heart disease underwent standardized CMR, echocardiography, and cardiopulmonary exercise testing (CPET) at least 3 years after the initial COVID-19. The primary endpoint was the association between %-predicted peak oxygen consumption (VO₂peak) (age-sex-body mass index (BMI) adjusted, Study of Health in Pomerania (SHIP) https://doi.org/10.1007/s00103-012-1483-6) and imaging parameters. Secondary analyses included lactate measurements and sex-stratified models.

A total of 132 participants (mean age 49±12 years; 68/132 (52%) male) were evaluated 48 months [interquartile range (IQR) 42-53] post-infection. Non-ischemic perimyocardial enhancement was present in 34/132 (26%), whereas two participants had an unrecognized ischemic scar. Male sex, higher BMI, lower age, and higher native T1 were associated with lower %-predicted VO₂peak in univariate models. In multivariate analysis, male sex, lower age, and higher native T1 (β = -0.25 per ms, 95% CI -0.40 to -0.10; p<0.001) remained independent predictors of lower %-predicted VO₂peak. In total, 63/132 (48%) participants demonstrated %-predicted VO₂peak below predicted values. Sex-stratified multivariate analyses showed that higher native T1 (p<0.001) independently associated with lower %-predicted VO₂peak in both men and women, with lower age additionally retained in men. In a lactate-measured subgroup (n = 73), higher resting lactate, higher native T1, male sex, and lower left atrial area were associated with lower %-predicted VO₂peak.

In long-term follow-up of individuals with mild initial COVID-19 and no prior structural heart disease, aerobic capacity relative to predicted values was reduced in 48% of participants, particularly in men, and was independently associated with higher myocardial native T1.